Your browser doesn't support javascript.
loading
Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial.
Rafii, Michael S; Sol, Olivier; Mobley, William C; Delpretti, Saskia; Skotko, Brian G; Burke, Anna D; Sabbagh, Marwan N; Yuan, Shauna H; Rissman, Robert A; Pulsifer, Margaret; Evans, Casey; Evans, A Carol; Beth, Gregory; Fournier, Nicolas; Gray, Julian A; Dos Santos, Antonio Melo; Hliva, Valerie; Vukicevic, Marija; Kosco-Vilbois, Marie; Streffer, Johannes; Pfeifer, Andrea; Feldman, Howard H.
Afiliación
  • Rafii MS; Alzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California, San Diego, San Diego.
  • Sol O; AC Immune SA, Lausanne, Switzerland.
  • Mobley WC; Department of Neuroscience, University of California, San Diego, San Diego.
  • Delpretti S; AC Immune SA, Lausanne, Switzerland.
  • Skotko BG; Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston.
  • Burke AD; Barrow Neurological Institute, Phoenix, Arizona.
  • Sabbagh MN; Barrow Neurological Institute, Phoenix, Arizona.
  • Yuan SH; Department of Neurology, University of Minnesota, Minneapolis.
  • Rissman RA; Department of Neuroscience, University of California, San Diego, San Diego.
  • Pulsifer M; Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston.
  • Evans C; Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston.
  • Evans AC; Department of Neuroscience, University of California, San Diego, San Diego.
  • Beth G; AC Immune SA, Lausanne, Switzerland.
  • Fournier N; AC Immune SA, Lausanne, Switzerland.
  • Gray JA; AC Immune SA, Lausanne, Switzerland.
  • Dos Santos AM; AC Immune SA, Lausanne, Switzerland.
  • Hliva V; AC Immune SA, Lausanne, Switzerland.
  • Vukicevic M; AC Immune SA, Lausanne, Switzerland.
  • Kosco-Vilbois M; AC Immune SA, Lausanne, Switzerland.
  • Streffer J; AC Immune SA, Lausanne, Switzerland.
  • Pfeifer A; AC Immune SA, Lausanne, Switzerland.
  • Feldman HH; Department of Neuroscience, University of California, San Diego, San Diego.
JAMA Neurol ; 79(6): 565-574, 2022 06 01.
Article en En | MEDLINE | ID: mdl-35532913
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / Síndrome de Down / Enfermedad de Alzheimer Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: JAMA Neurol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / Síndrome de Down / Enfermedad de Alzheimer Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: JAMA Neurol Año: 2022 Tipo del documento: Article